Abstract
Multiple laser systems for the treatment of benign prostatic hyperplasia (BPH) have been introduced. Current laser systems have limitations due to their laser physics. The RevoLix™ laser combines the advantages of the Holmium:YAG laser with the comfort of a continuous wave (cw) laser beam. This study reports the preliminary results of vaporesection (simultaneous vaporization and resection) of the prostate, using the 2 μm cw laser. A total of 54 consecutive patients were treated with the 70 W RevoLix™ laser for BPH. The mean age was 61 years. Mean prostate volume was 30.3 cc. A 550 μm RigiFib™ bare-ended fiber was used in combination with a 26 French laser resectoscope. Measured outcomes were resection time, decrease in hemoglobin and transfusion rate. Furthermore, the catheter time, improvement in the urinary flow rate (Q max), post-voiding residual urine (PVR), International Prostate Symptom Score (IPSS) and Quality of Life Index (QoL) were recorded. Average resection time was 52 min. After crossing the learning curve, a tissue ablation of 1.5 g/min was possible. Transfusions were not necessary in any patient. Catheter time was 1.7 days. Q max significantly improved from 4.2 to 20.1 ml on average. PVR decreased from 86 to 12 ml. IPSS and QoL-Score improved from 19.8 to 6.9 and 4 to 1, respectively. No patient required re-hospitalization. These preliminary results indicate that RevoLix™ vaporesection of the prostate is safe and efficient. One-year follow-up data showed a significant improvement in voiding symptoms and patients’ quality of life. A longer follow-up is needed to prove the durability of these promising results.
Similar content being viewed by others
References
Mebust WK, Holtgrewe HL, Cockett AT, Peters PC (2002) Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 167:999–1003
Aho TF, Gilling PJ (2003) Laser therapy for benign prostatic hyperplasia: a review of recent developments. Curr Opin Urol 13:39–44
Kuntz RM (2006) Current role of Lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol 49:961–969
Muschter R, Perlmutter AP (1994) The optimization of laser prostatectomy II: other techniques. Urology 44:856–861
Madersbacher S, Marberger M (1999) Is transurethral resection of the prostate still justified ? BJU Int 83:227
Schatzl G, Madersbacher S, Djavan B, Lang T, Marberger M (2000) Two-year results of transurethral resction of the prostate versus four “less invasive” treatment options. Eur Urol 37:695
Sulser T, Reich O, Wyler S, Ruszat R, Casella R, Hofstetter A, Bachmann A (2004) Photoselective KTP laser vaporisation of the prostate: first experiences with 65 procedures. J Endourol 18:976–981
Horninger W, Unterlechner H, Strasser H, Bartsch G (1996) Transurethral prostatectomy: mortality and morbidity. Prostate 28:195–200
Borboroglu PG, Kane CJ, Ward JF, Roberts JL, Sands JP (1999) Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol 162:1307–1310
Mebust WK, Holtgrewe HL, Cockett AT, Peters PC (1989) Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 141:243–247
Roos NP, Wennberg JE, Malenka DJ, Fisher DJ, Fisher ES, McPherson K, Andersen TF, Cohen MM, Ramsey E (1989) Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 320:1120–1124
Costello AJ, Bowsher WG, Bolton DM, Braslis KG, Burt J (1992) Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol 69:603–608
Muschter R, Whitfield H (1999) Interstial laser therapy of benign prostatic hyperplasia. Eur Urol 35:147–154
Laguna MP, Alivizatos G, De la Rosette JJ (2003) Interstitial laser coagulation treatment of benign prostatic hyperplasia: is it to be recommended. J Endourol 17:595–600
Muschter R (2003) Free-beam and contact laser coagulation. J Endourol 17:579–85
Hoffmann RM, MacDonald R, Slaton JW, Wilt TJ (2003) Laser prostatectomy versus transurethral resection for treating benign prostatic obstruction: a systemic review. J Urol 169:210–215
Te AE (2004) The development of laser prostatectomy. BJU Int 93:262–265
Hofstetter A (1991) Interstitielle Thermokoagulation (ITK) von Prostatatumoren. Laser Med 7:179
Jacques SL (1992) Laser tissue interaction. Photochemical, photodermal and photomechanical. Surg Clin North Am 75:531–558
Wilson LC, Gilling PJ (2005) From coagulation to enucleation: the use of lasers in surgery for benign prostatic hyperplasia. Nat Clin Pract Urol 2:443–448
Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE (2004) High-power potassium-titanyl-phophate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 64:1155–1159
Gilling PJ, Fraundorfer MR (1998) Holmium laser prostatectomy: a technique in evolution. Curr Opin Urol 8:11–15
Das A, Kennett KM, Sutton T, Fraundorfer MR, Gilling PJ (2000) Histologic effects of holmium:YAG laser resection versus transurethral resection of the prostate. J Endourol 14:459–462
Kuo RL, Kim SC, Lingeman JE, Paterson RF, Watkins SL, Simmons GR, Steele RE (2003) Holmium laser enucleation of prostate (HoLEP): the Methodist Hospital experience with greater than 75 gram enucleations. J Urol 170:149–152
Elzayat EA, Elhilali MM (2006) Holmium laser enucleation of the prostate (HoLEP): the endourologic alternative to open prostatectomy. Eur Urol 49(1):87–91
Madersbacher S, Marszalek M, Ponholzer A, Brossner C (2004) Holmium laser-enucleation of the prostate enables early catheter removal. BJU Int 94:931–933
Tan AH, Gilling PJ (2003) Holmium laser prostatectomy. BJU Int 92:527–30
Elzayat EA, Elhilali MM (2006) Laser treatment of symptomatic benign prostatic hyperplasia. World J. Urol 24:410–417
Seki N, Mochida O, Kinukawa N, Sagiyama K, Nato S (2003) Holmium laser enucleation for prostatic adenom: Analysis of learning curve over the curse of 70 consecutive cases. J Urol 170:1847–1850
Vavassori I, Hurle R, Vismara A, Manzetti A, Valenti S (2004) Holmium laser enucleation of the prostate combined with mechanical morcellation: two years of experience with 196 patients. J Endourol 18:109–112
Kuo RL, Paterson RF, Siqueira TM Jr, Watkins SL, Simmons GR, Steele RE, Lingeman JE (2003) Holmium laser enucleation of the prostate: morbidity in a series of 206 patients. Urology 62:59–63
Malek RS, Kuntzman RS, Barrett DM (2005) Photoselective potassium-titanyl-phosphate laser vaporisation of the benign obstructive prostate: observations onlong-term outcomes. J Urol 174:1344–1348
Author information
Authors and Affiliations
Corresponding author
Additional information
T. Bach and T.R.W. Herrmann contributed equally to this paper.
Rights and permissions
About this article
Cite this article
Bach, T., Herrmann, T.R.W., Ganzer, R. et al. RevoLix™ vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up. World J Urol 25, 257–262 (2007). https://doi.org/10.1007/s00345-007-0171-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-007-0171-x